Attovia Therapeutics, Inc. (ATTO) vs Cytek Biosciences, Inc. (CTKB)
A side-by-side comparison of Attovia Therapeutics, Inc. and Cytek Biosciences, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ATTO
Attovia Therapeutics, Inc.
$17.71HealthcareDelayed quote: Oct 6, 2026, 10:05 AM EDT
CTKB
Cytek Biosciences, Inc.
$5.97HealthcareDelayed quote: Oct 6, 2026, 10:05 AM EDT
Total return — ATTO vs CTKB
growth of $100 · dividends reinvested · last 1yATTO -17.8% (-17.8%/yr)CTKB +42.3% (+42.3%/yr)CTKB compounded faster over this window
ATTO CTKB
ATTO vs CTKB: by the numbers
- •CTKB is the larger company ($770M vs $762M market cap).
- •Both run net losses; CTKB's is the smaller (-38.98% vs -4490.89% net margin).
Metrics side by side
Valuation
| Metric | ATTO | CTKB |
|---|---|---|
| P/S ratio | N/A | 3.73 |
| P/B ratio | N/A | 2.39 |
Profitability
| Metric | ATTO | CTKB |
|---|---|---|
| Gross margin | 40.44% | 53.23% |
| Operating margin | -4974.74% | -21.60% |
| Net margin | -4490.89% | -38.98% |
| ROE | -40.21% | -25.03% |
| ROIC | -42.83% | -12.00% |
Growth (annualized)
| Metric | ATTO | CTKB |
|---|---|---|
| Revenue CAGR (5Y) | N/A | 13.37% |
| Total return CAGR (5Y) | N/A | -23.16% |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.